Eczema Global Market Report 2025

Description

Eczema is a chronic inflammatory skin condition marked by redness, itching, dryness, and irritation. It results from a combination of genetic and environmental factors, leading to a weakened skin barrier and an overactive immune response. While eczema can affect individuals of all ages, it is more common in children. The condition often occurs in flare-ups triggered by allergens, irritants, stress, or climate changes.

The primary types of eczema include atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other variations. Atopic dermatitis, commonly referred to as eczema, is a chronic skin disorder characterized by itchy, red, and inflamed skin, often aggravated by allergens, irritants, or stress. Treatment options for eczema include topical treatments, oral medications, biologics, and phototherapy. The condition affects various age groups, including children, adults, and the elderly, and is managed across different healthcare settings such as hospitals, clinics, dermatology centers, home care, and pharmacies.

The eczema market research report is one of a series of new reports from The Business Research Company that provides eczema market statistics, including the eczema industry global market size, regional shares, competitors with the eczema market share, detailed eczema market segments, market trends, and opportunities, and any further data you may need to thrive in the eczema industry. This eczema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The eczema market size has grown strongly in recent years. It will grow from $16.41 billion in 2024 to $17.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing prevalence of autoimmune diseases, the rising cases of eczema, greater regulatory approvals, the growing incidence of air pollution, and the increasing burden of allergic reactions.

The eczema market size is expected to see strong growth in the next few years. It will grow to $24.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising demand for atopic dermatitis treatment, increasing operational activities, greater awareness of eczema, the growing use of biologics, and the expanding adoption of telemedicine platforms. Key trends in the forecast period include strategic collaborations, the development of emerging therapies, the rise of injectable drugs, and the advancement of personalized medicine.

The rising prevalence of autoimmune disorders is expected to drive the expansion of the eczema market in the coming years. Autoimmune disorders occur when the body's immune system mistakenly attacks healthy cells, tissues, or organs, leading to inflammation and damage. The growing incidence of these conditions is linked to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle influences such as stress and exposure to pollutants. Autoimmune diseases such as psoriasis, lupus, and rheumatoid arthritis are associated with dysregulated immune responses, increasing the likelihood of eczema and other inflammatory skin conditions. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Consequently, the increasing prevalence of autoimmune disorders is fueling the growth of the eczema market.

Leading companies in the eczema market are focusing on developing innovative products, such as advanced eczema care creams, to improve treatment effectiveness and meet the growing demand for specialized skincare solutions. Eczema care creams are formulated to soothe, hydrate, and protect affected skin, reducing itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, including the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. This product line is designed specifically for infants with eczema, featuring 100% skin-natural nutrients to ensure gentleness on sensitive skin. Additionally, the formulations contain colloidal oatmeal (1.0%), a key ingredient known for soothing irritation and maintaining skin moisture.

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for approximately $850 million. This acquisition aims to strengthen Johnson & Johnson's position in treating atopic dermatitis (AD) and asthma by integrating innovative bispecific antibody therapies into its product portfolio. Proteologix Inc. is a US-based biotechnology company specializing in the development of bispecific antibodies for immune-mediated diseases.

Major players in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc.

North America was the largest region in the eczema market in 2024. The regions covered in eczema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eczema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eczema market consists of revenues earned by entities by providing services such as diagnosis and consultation services, prescription and medication services, phototherapy services, allergy testing and immunotherapy, and skin barrier repair therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The eczema market also includes sales of antihistamines, topical corticosteroids, calcineurin inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eczema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eczema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eczema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eczema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Atopic Dermatitis; Contact Dermatitis; Seborrheic Dermatitis; Other Types
2) By Treatment Type: Topical Treatments; Oral Medications; Biologics; Phototherapy
3) By Age Group: Children; Adults; Elderly
4) By End User: Hospitals Or Clinics; Dermatology Centers; Home Care; Pharmacies
Subsegments:
1) By Atopic Dermatitis: Topical Steroids; Topical Calcineurin Inhibitors; Moisturizers; Biologic Therapies
2) By Contact Dermatitis: Topical Steroids; Antihistamines; Topical Immunosuppressants; Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos; Topical Steroids; Medicated Shampoos; Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis; Nummular Dermatitis; Neurodermatitis; Dyshidrotic Eczema
Companies Mentioned: Pfizer Inc.; AbbieVie Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34045

1. Executive Summary

2. Eczema Market Characteristics

3. Eczema Market Trends And Strategies

4. Eczema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Eczema Growth Analysis And Strategic Analysis Framework

5.1. Global Eczema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Eczema Market Growth Rate Analysis
5.4. Global Eczema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Eczema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Eczema Total Addressable Market (TAM)

6. Eczema Market Segmentation

6.1. Global Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atopic Dermatitis
Contact Dermatitis
Seborrheic Dermatitis
Other Types
6.2. Global Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Treatments
Oral Medications
Biologics
Phototherapy
6.3. Global Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adults
Elderly
6.4. Global Eczema Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals Or Clinics
Dermatology Centers
Home Care
Pharmacies
6.5. Global Eczema Market, Sub-Segmentation Of Atopic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Steroids
Topical Calcineurin Inhibitors
Moisturizers
Biologic Therapies
6.6. Global Eczema Market, Sub-Segmentation Of Contact Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Steroids
Antihistamines
Topical Immunosuppressants
Wet Compresses
6.7. Global Eczema Market, Sub-Segmentation Of Seborrheic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Creams or Shampoos
Topical Steroids
Medicated Shampoos
Topical Calcineurin Inhibitors
6.8. Global Eczema Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Dermatitis
Nummular Dermatitis
Neurodermatitis
Dyshidrotic Eczema

7. Eczema Market Regional And Country Analysis

7.1. Global Eczema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Eczema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eczema Market

8.1. Asia-Pacific Eczema Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eczema Market

9.1. China Eczema Market Overview
9.2. China Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eczema Market

10.1. India Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eczema Market

11.1. Japan Eczema Market Overview
11.2. Japan Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eczema Market

12.1. Australia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eczema Market

13.1. Indonesia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eczema Market

14.1. South Korea Eczema Market Overview
14.2. South Korea Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eczema Market

15.1. Western Europe Eczema Market Overview
15.2. Western Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eczema Market

16.1. UK Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eczema Market

17.1. Germany Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eczema Market

18.1. France Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eczema Market

19.1. Italy Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eczema Market

20.1. Spain Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eczema Market

21.1. Eastern Europe Eczema Market Overview
21.2. Eastern Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eczema Market

22.1. Russia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eczema Market

23.1. North America Eczema Market Overview
23.2. North America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eczema Market

24.1. USA Eczema Market Overview
24.2. USA Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eczema Market

25.1. Canada Eczema Market Overview
25.2. Canada Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eczema Market

26.1. South America Eczema Market Overview
26.2. South America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eczema Market

27.1. Brazil Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eczema Market

28.1. Middle East Eczema Market Overview
28.2. Middle East Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eczema Market

29.1. Africa Eczema Market Overview
29.2. Africa Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eczema Market Competitive Landscape And Company Profiles

30.1. Eczema Market Competitive Landscape
30.2. Eczema Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbieVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Eczema Market Other Major And Innovative Companies

31.1. AstraZeneca PLC
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Amgen
31.5. Hoffmann-La Roche AG
31.6. Eli Lilly and Co.
31.7. Siemens Healthineers AG
31.8. Viatris Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Regeneron Pharmaceuticals Inc.
31.11. Astellas Pharma Inc
31.12. Bausch Health Companies Inc.
31.13. Galderma
31.14. Cadila Pharmaceuticals Ltd.
31.15. LEO Pharma A/S

32. Global Eczema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eczema Market

34. Recent Developments In The Eczema Market

35. Eczema Market High Potential Countries, Segments and Strategies

35.1 Eczema Market In 2029 - Countries Offering Most New Opportunities
35.2 Eczema Market In 2029 - Segments Offering Most New Opportunities
35.3 Eczema Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer